LM-299
Based on 1 Customer Validation
LM-299 is a bispecific antibody targeting PD-1 and VEGF with anti-tumor activity. The dual binding activity of LM-299 is achieved through the effective binding of its Fab-terminal anti-VEGF-A antibody to human VEGF-A, as well as the blocking effect of its Fc-terminal anti-PD-1 antibody on the PD-1/PD-L1 pathway. LM-299 binds to and modulates PD-1 and VEGF. LM-299 can be used in studies related to advanced malignant tumors, advanced solid tumors, and advanced non-small cell lung cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 95.78%
- 分子量:175.49 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Target
PD-1 & VEGF
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Human PD-1 Protein, His Tag can bind LM-299. The EC50 for this effect is 164.3 ng/mL. -
Immobilized Human VEGF165 Protein,hFc Tag can bind LM-299. The EC50 for this effect is 77.9 ng/mL.
Product Details
Product Properties
-
性状
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
純度
95.78%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)